AMICUS THERAPEUTICS, INC.
|
12,339,444
|
$73,420,000
|
7.43%
|
No Change
|
+$32,206,000
|
NEUROCRINE BIOSCIENCES INC
|
4,565,267
|
$71,538,000
|
7.24%
|
-34,600
|
+$3,276,000
|
Affimed N.V.
|
999,989
|
$63,006,000
|
6.38%
|
New
|
+$63,006,000
|
Sarepta Therapeutics, Inc.
|
2,596,691
|
$54,790,000
|
5.55%
|
+38,213
|
-$21,427,000
|
ACELRX PHARMACEUTICALS INC
|
6,574,060
|
$36,092,000
|
3.65%
|
No Change
|
-$31,292,000
|
Celgene Corp
|
377,448
|
$35,775,000
|
3.62%
|
-130,040
|
-$7,805,000
|
PTC THERAPEUTICS, INC.
|
671,736
|
$29,563,000
|
2.99%
|
No Change
|
+$12,004,000
|
Dyax Corp
|
2,835,498
|
$28,695,000
|
2.90%
|
+124,900
|
+$2,673,000
|
ACADIA PHARMACEUTICALS INC
|
1,097,914
|
$27,184,000
|
2.75%
|
+444,914
|
+$12,433,000
|
VERTEX PHARMACEUTICALS INC / MA
|
240,142
|
$26,970,000
|
2.73%
|
-230,000
|
-$17,543,000
|
Sarepta Therapeutics, Inc.
CALL
|
1,250,000
|
$26,375,000
|
2.67%
|
New
|
+$26,375,000
|
ZIMMER BIOMET HOLDINGS, INC.
|
252,500
|
$25,389,000
|
2.57%
|
+10,000
|
+$203,000
|
TARO PHARMACEUTICAL INDUSTRIES LTD
|
140,935
|
$21,684,000
|
2.19%
|
-160,398
|
-$20,576,000
|
LION BIOTECHNOLOGIES
|
2,914,549
|
$20,839,000
|
2.11%
|
-97,000
|
+$1,566,000
|
IVERIC bio, Inc.
|
520,165
|
$20,250,000
|
2.05%
|
+148,696
|
+$4,533,000
|
OTONOMY, INC.
|
837,400
|
$20,098,000
|
2.03%
|
New
|
+$20,098,000
|
Receptos Inc
|
313,594
|
$19,477,000
|
1.97%
|
+108,594
|
+$10,744,000
|
Tesaro Inc
|
708,284
|
$19,067,000
|
1.93%
|
+71,328
|
-$749,000
|
ARROWHEAD PHARMACEUTICALS, INC.
|
1,247,495
|
$18,426,000
|
1.86%
|
+825,089
|
+$12,381,000
|
Xencor Inc
|
1,922,707
|
$17,900,000
|
1.81%
|
+182,086
|
-$2,326,000
|
HCA Healthcare, Inc.
|
230,306
|
$16,241,000
|
1.64%
|
+32,500
|
+$5,089,000
|
Relypsa Inc
|
762,705
|
$16,085,000
|
1.63%
|
+166,100
|
+$1,576,000
|
ACCELERON PHARMA INC
|
445,000
|
$13,457,000
|
1.36%
|
+145,000
|
+$3,266,000
|
Retrophin, Inc.
|
1,379,137
|
$12,438,000
|
1.26%
|
+104,845
|
-$2,522,000
|
Aegerion Pharmaceuticals Inc
|
366,754
|
$12,242,000
|
1.24%
|
New
|
+$12,242,000
|